| P/E (FY) | — | Sales (TTM) | $204.2M |
| Earnings (TTM) | -$74.0M | ROE | −18.05% |
| Net Margin | −33.02% | ROIC | −11.65% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 308.17% |
Cytek Biosciences is a cell analysis solutions company providing tools for biomedical research and clinical applications. Its instruments include the Cytek Aurora, Northern Lights, and Aurora Evo systems for cell analysis, the Aurora CS System, Amnis ImageStream imaging flow cytometers, Guava Muse and Muse Micro cell analyzers, Guava EasyCyte flow cytometers, and Orion reagent cocktail preparation systems. It also offers reagents and kits, including cFluor fluorochrome-conjugated antibodies, and automated micro-sampling systems.
| Market Cap | $576.0M | Trading Days | 1252 |
| 52W High | 6.18 |
| 52W Low | 3.28 |
| % Off High | −27.83% |
| YTD | −11.68% | 1Y | 18.93% |
| 3Y | −50.39% | 5Y | −77.53% |
| Since incept. (ann.) | −24.27% |
Reportable 100%
| Ann. Volatility (1Y) | 56.54% | Ann. Volatility (3Y) | 64.79% |
| Sharpe (1Y) | 0.59 | Sharpe (3Y) | −0.04 |
| Max Drawdown (1Y) | −42.94% | Max Drawdown (3Y) | −74.55% |
| Beta (3Y, vs SPY) | 2.22 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $431.7M | — |
| EYPT | EyePoint, Inc. | $1.00B | — |
| LAB | STANDARD BIOTOOLS INC. | $310.0M | — |
| HBIO | HARVARD BIOSCIENCE INC | $262.8M | — |
| ALMR | Alamar Biosciences, Inc. | $1.69B | — |
| QTRX | Quanterix Corp | $164.4M | — |
| NAUT | Nautilus Biotechnology, Inc. | $152.5M | — |
| ASTC | ASTROTECH Corp | $124.9M | — |
| SEER | Seer, Inc. | $117.7M | — |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | $92.0M | — |
| TXG | 10x Genomics, Inc. | $5.87B |
| — |
| PRPO | Precipio, Inc. | $40.5M | — |
